Fractalkine/CX(3)CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?

Dilated cardiomyopathy (DCM) is a cardiac condition with structural and functional impairment, where either the left ventricle or both ventricular chambers are enlarged, coinciding with reduced systolic pump function (reduced ejection fraction, rEF). The prevalence of DCM is more than 1:250 individu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeyalan, Visvesh, Austin, David, Loh, Shu Xian, Wangsaputra, Vincent Kharisma, Spyridopoulos, Ioakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571889/
https://www.ncbi.nlm.nih.gov/pubmed/37830591
http://dx.doi.org/10.3390/cells12192377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571889/
https://www.ncbi.nlm.nih.gov/pubmed/37830591
http://dx.doi.org/10.3390/cells12192377

Ejemplares similares